ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases
ASH Update on MDS Management: What Are the Outcomes of Venetoclax for Higher Risk MDS? Can We Expect to See Venetoclax + AZA as a New SoC?
Comments 0
Login to view comments.
Click here to Login
